|
|
Post by lakers on Aug 7, 2018 1:46:18 GMT -5
|
|
|
|
Post by akemp3000 on Aug 7, 2018 5:25:15 GMT -5
Loved... "MannKind Corp., Westlake Village, Calif., which makes Afrezza, has been selling the inhaler in the U.S. for a few years now, and sales are growing rapidly. In its most recent quarter, the company posted Afrezza sales of $3.4 million, up 184 percent from the year-earlier period."
We all know sales haven't yet grown as rapidly as needed but this company is moving in the right direction and the smart money, meaning institutional investors and inside buyers, know this. It's been a very long journey but the end of this particular Wall Street war is near and MNKD is going to win.
|
|
